Page last updated: 2024-11-07

lynestrenol and Cell Transformation, Neoplastic

lynestrenol has been researched along with Cell Transformation, Neoplastic in 2 studies

Lynestrenol: A synthetic progestational hormone used often in mixtures with estrogens as an oral contraceptive (CONTRACEPTIVES, ORAL).

Cell Transformation, Neoplastic: Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill.

Research Excerpts

ExcerptRelevanceReference
" High norgestrel dosages caused atrophies of the corpus endometrium significantly more often than low norgestrel dosages, desogestrel or lynestrenol at low dosage levels."1.27[Dependence of morphologic changes in portio, cervix and endometrium on dosage or potency of synthetic gestagens]. ( Dallenbach-Hellweg, G; Fenzel, J, 1985)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wybran, J1
Thiry, L1
Dallenbach-Hellweg, G1
Fenzel, J1

Other Studies

2 other studies available for lynestrenol and Cell Transformation, Neoplastic

ArticleYear
Delay of tumor growth in hamsters treated with lynestrenol and effect of Staphylococcus aureus Cowan A.
    Journal of the National Cancer Institute, 1978, Volume: 61, Issue:1

    Topics: Animals; Antigens, Neoplasm; Cell Transformation, Neoplastic; Cricetinae; Female; Immunity; Immunoth

1978
[Dependence of morphologic changes in portio, cervix and endometrium on dosage or potency of synthetic gestagens].
    Geburtshilfe und Frauenheilkunde, 1985, Volume: 45, Issue:4

    Topics: Cell Transformation, Neoplastic; Cervix Uteri; Desogestrel; Dose-Response Relationship, Drug; Endome

1985